Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy

Pathology

Volumn 42, Issue 2, 2010, Pages 138-146

  Liszka, Łukasz ^a   Paja̧k, Jacek ^a   Zieliska Pajk, Ewa ^a   Gołka, Dariusz ^b   Mrowiec, Sławomir ^a   Lampe, Paweł ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Lymph node; Pancreatectomy; Pancreatic ductal carcinoma

Indexed keywords

EID: 75649139488     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903494060     Document Type: Article

References (33)

1. Khalifa MA. Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 2007; 60: 975-980
2. Khalifa MA, Maksymov V, Rowsell C. Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist. Virchows Arch 2009; 454: 125-131
3. Gill AJ, Johns AL, Eckstein R, et al. Synoptic reporting improves histopathological assessment of pancreatic resections specimens. Pathology 2009; 41: 161-167
4. Verbeke CS. Resection margins and R1 rates in pancreatic cancer - are we there yet? Histopathology 2008; 52: 787-796
5. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs. orange-peeling approach in pathologic assessment. Mod Pathol 2009; 22: 107-112
6. Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006; 93: 1232-1237
7. Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008; 15: 1651-1660
8. Verbeke CS. Resection margins and R1 rates in pancreatic cancer - are we there yet? (Reply.) Histopathology 2008; 53: 599.
9. Raut CP, Evans DB. Reply. Ann Surg 2008; 247: 717-718
10. Warren BF. Resection margins and R1 rates in pancreatic cancer - are we there yet? (Correspondence.) Histopathology 2008; 53: 599.
11. Greene FL, Compton CC, Fritz AG, et al. American Joint Committee on Cancer Staging Atlas. Chicago: Springer, 2006.
12. Hruban RH, Pitman MB, Klimstra DS. AFIP Atlas of Tumor Pathology. Tumors of the Pancreas. Fourth Series; Fascicle 6. Washington: American Registry of Pathology, Armed Forces Institute of Pathology; 2007.
13. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457
14. Katz MH, Hwang R, Fleming JB, et al. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA J Cancer Clin 2008; 58: 111-125
15. Verbeke CS, Menon KV. Variability in reporting resection margin status in pancreatic cancer. Ann Surg 2008; 247: 716-717
16. Raut CP, Tseng JF, Sun CC, et al. Impact of resection margin status on pattern of failure and survival after pancreaticoduodenectomy for the pancreatic adenocarcinoma. Ann Surg 2007; 246: 52-60.
17. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001; 234: 758-768
18. Butturini G, Stocken DD, Wente MN, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer. Arch Surg 2008; 143: 75-83.
19. Mabry CD. Invited critique. Arch Surg 2008; 143: 83.
20. Fusai G, Warnaar N, Sabin CA, et al. Outcome of R1 resection in patients undergoing pancreatico-duodenectomy for pancreatic cancer. Eur J Surg Oncol 2008; 34: 1309-1315
21. Evans DB, Hess KR, Pisters PWT. Letter to the editor. Ann Surg 2002; 236: 694.
22. Pandey D. Letter to the Editor. Br J Surg 2007; 94: 119-122
23. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006; 13: 1189-1200
24. Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of staging nodenegative pancreas cancer. A potential quality measure. Arch Surg 2007; 142: 767-774
25. Bilchik A. Discussion. Arch Surg 2007; 142: 773.
26. Pawlik TM, Gleisner AM, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141: 610-618
27. Gutierrez JC, Franceschi D, Koniaris LG. How many lymph nodes properly stage a periampullary malignancy? J Gastrointest Surg 2008; 12: 77-85.
28. Thorn CC, Woodcock NP, Scott N, et al. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 2004; 6: 356-361
29. Morimoto H, Ajiki T, Ueda T, et al. Histological features of lymph node metastasis in patients with biliary tract cancer. J Surg Oncol 2008; 97: 423-427
30. Parfitt JR, Driman DK. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol 2007; 60: 849-855
31. Nagtegaal ID, van de Velde CJH, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-1734
32. Quirke P, Morris E. Reporting colorectal cancer. Histopathology 2007; 50: 103-112
33. Bockhorn M, Cataldegirmen G, Kutup A, et al. Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability. Ann Surg Oncol 2009; 16: 1212-1221